LATEST NEWS
PREVENTATIVE PRACTICE: why change is needed to reduce multiple burdens on the NHS
FIND OUT MORE | 5 Minute read
MOST POPULAR READS
Lack of collaboration the biggest challenge in adopting blockchain, says IBM
READ MORE | 3 Minute Read
Industry’s shift towards large molecules and how to maintain balance
READ MORE | 4 Minute Read
Backend, Baffling and Buzzing: Blockchain
READ MORE | 20 Minute Read
Technology
READ MORE | 7 Minute Read
The future of the pharmaceutical industry
READ MORE | 12 Minute Read
LIFE SCIENCE INTEGRATES INDUSTRY INSIGHTS
Treatment
READ MORE | 5 Minute Read
Technology
READ MORE | 7 minute read
Talent
READ MORE | 5 Minute Read
Tactics
READ MORE | 5 Minute Read
Considering The Patient
READ MORE | 5 Minute Read
Catapults
READ MORE | 5 Minute Read
MARCO MOHWINCKEL INSIGHTS
Marco Mohwinckel: Revolutionising Drug Discover With Big Data And AI
READ MORE | 10 Minute Read
Marco Mohwinckel:
Backend and Buzzing:
Blockchain
READ MORE | 20 Minute Read
Marco Mohwinckel:
The Disruptive Power
of Pharma AI
READ MORE | 10 Minute Read
VISIT OUR INSIGHTS AREAS
WHITE PAPERS
Data Integrity – A Closer Look
Data integrity remains a perennial hot topic impacting the pharma biotech industry and the trend has been picking up steam; the number of data integrity-related warning letters has increased consistently since 2010. A number of new guidance documents came out in 2016...
Is fear of risk your biggest fear?
Why becoming more risk literate is so vital
Navigating Market Access For Cell & Gene Therapy
A substantial number of cell and gene therapies (C>s) delivering a cure or at least durable health benefits are expected over the next 5 to 10 years – for example, MIT NEWDIGS researchers estimated that about 40 gene therapies may be approved by the end of 2022.
LATEST NEWS
HPC Innovators, Dr Steven Newhouse (EMBL-EBI)
Dr Steven Newhouse is the Head of Technical Services at EMBL's European Bioinformatics Institute (EMBL-EBI). He has previously held roles in the leadership of European Grid Infrastructure activities and was a Program Manager in the High Performance Computing (HPC)...
Registration is now OPEN for the CMAC Virtual Open Day
Registration is now OPEN for the CMAC Virtual Open Day taking place across two afternoons of Wednesday 21st and Thursday 22nd October 2020.
Cancer Research UK: Early Detection and Diagnosis Research
Detecting cancers at an early stage has the potential to revolutionise patient outcomes. Patients diagnosed early, at stages 1 and 2, have the best chance of curative treatment and long-term survival.
INDUSTRY INSIGHTS
Treatment
A key part of Pharma Integrates’ agenda revolved around the efficacy of different types of treatment, how to get therapies to patients quickly and effectively, the impact of personalised medicine, technological advances in drug discovery and tackling rare diseases.
Technology
With investment in the digital health sector reaching a record $8.1bn (£6.2bn) in 2018 and with one third of all US healthcare investment now in digital health technology, it is becoming increasingly important that the life sciences sector keeps up to date with the latest technological advances.
Talent
A company’s staff is its greatest asset, but with every business struggling to recruit and retain key talent, and with the very real threat of a Brexit “brain drain”, how can the life sciences industry attract the best and brightest?
Tactics
In an ever-changing pharmaceutical industry, both in terms of innovation and R&D, as well as from a business and funding perspective, the subject of strategic development and tactics to boost productivity was firmly on the agenda at November’s Pharma Integrates.
ON TWITTER
WHITE PAPERS
Data Integrity – A Closer Look
Data integrity remains a perennial hot topic impacting the pharma biotech industry and the trend has been picking up steam; the number of data integrity-related warning letters has increased consistently since 2010. A number of new guidance documents came out in 2016...
Is fear of risk your biggest fear?
Why becoming more risk literate is so vital
Navigating Market Access For Cell & Gene Therapy
A substantial number of cell and gene therapies (C>s) delivering a cure or at least durable health benefits are expected over the next 5 to 10 years – for example, MIT NEWDIGS researchers estimated that about 40 gene therapies may be approved by the end of 2022.
LATEST NEWS
HPC Innovators, Dr Steven Newhouse (EMBL-EBI)
Dr Steven Newhouse is the Head of Technical Services at EMBL's European Bioinformatics Institute (EMBL-EBI). He has previously held roles in the leadership of European Grid Infrastructure activities and was a Program Manager in the High Performance Computing (HPC)...
Registration is now OPEN for the CMAC Virtual Open Day
Registration is now OPEN for the CMAC Virtual Open Day taking place across two afternoons of Wednesday 21st and Thursday 22nd October 2020.
Cancer Research UK: Early Detection and Diagnosis Research
Detecting cancers at an early stage has the potential to revolutionise patient outcomes. Patients diagnosed early, at stages 1 and 2, have the best chance of curative treatment and long-term survival.
INDUSTRY INSIGHTS
Treatment
A key part of Pharma Integrates’ agenda revolved around the efficacy of different types of treatment, how to get therapies to patients quickly and effectively, the impact of personalised medicine, technological advances in drug discovery and tackling rare diseases.
Technology
With investment in the digital health sector reaching a record $8.1bn (£6.2bn) in 2018 and with one third of all US healthcare investment now in digital health technology, it is becoming increasingly important that the life sciences sector keeps up to date with the latest technological advances.
Talent
A company’s staff is its greatest asset, but with every business struggling to recruit and retain key talent, and with the very real threat of a Brexit “brain drain”, how can the life sciences industry attract the best and brightest?
Tactics
In an ever-changing pharmaceutical industry, both in terms of innovation and R&D, as well as from a business and funding perspective, the subject of strategic development and tactics to boost productivity was firmly on the agenda at November’s Pharma Integrates.
ON TWITTER
PREVIOUS EVENTS
Sign up for life science integrates news
Get the latest news and updates by signing up today.
By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.